Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.84 |
| ▸ | MAPT | P10636 | 1/20 | 0.84 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.50 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.48 |
| ▸ | F2 | P00734 | 2/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.48 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.48 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4104788 | 1.00 | ALDH1A1 (0.84) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL11759173 | 1.00 | ALDH1A1 (0.84) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL14968385 | 1.00 | ALDH1A1 (0.84) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| Bromide SCHEMBL28355691 | 0.97 | ALDH1A1 (0.80) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL4970157 | 0.97 | ALDH1A1 (0.89) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL2065279 | 0.92 | ALDH1A1 (1.00) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL18660199 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL18660177 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL19018359 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTL3MBTL1HDAC3HDAC1 | |
| SCHEMBL8628601 | 0.91 | ALDH1A1 (0.77) | ALDH1A1MAPTL3MBTL1MAOASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2999736-A1 | METHOD OF AEROGEL SYNTHESIS | NeXolve Corporation (US) | 2016-03-30 | — | — | EP | claimed |
| EP-4638539-A1 | COATING COMPOSITIONS WITH CATALYTIC SYSTEM | PPG Industries Ohio, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| WO-2024137905-A1 | COATING COMPOSITIONS WITH CATALYTIC SYSTEM | PPG INDUSTRIES OHIO, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-0934924-B1 | NOVEL DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-6576642-B2 | Inhibitors of the production of Ig E antibodies, antiallergens | KOWA CO., LTD. (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20010039279-A1 | Diamide compounds and compositions containing the same | KOWA CO., LTD. (JP) | 2001-11-08 | — | — | US | disclosed |
| US-6297283-B1 | EXCELLENT INHIBITORY EFFECT ON THE PRODUCTION OF AN IGE ANTIBODY AND ARE HENCE USEFUL AS ANTIALLERGIC AGENTS | KOWA CO., LTD. (JP) | 2001-10-02 | — | — | US | disclosed |
| US-6143917-A | FROM A DIARYL CARBONATE AND AN AMINE COMPOUND HAVING AT LEAST ONE HYDROGEN ATOM LOCATED AT AN N-POSITION UNDER MODERATE CONDITIONS AT A HIGH REACTION RATE WITH A HIGH SELECTIVITY AND WITH A HIGH YIELD | UBE INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| EP-0934924-A1 | NOVEL DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO. LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
| EP-0902014-A1 | PROCESS FOR PRODUCING ARYL CARBAMATES | UBE INDUSTRIES LIMITED (JP) | 1999-03-17 | — | — | EP | disclosed |
| EP-0308745-B1 | THICKENED MOULDING COMPOSITION | BASF Aktiengesellschaft (DE) | 1992-11-19 | — | — | EP | disclosed |
| US-5047455-A | Containing liquid, polymerizable reactive system, isocyanate, initiator and additive shelf life | BASF AKTIENGESELLSCHAFT (DE) | 1991-09-10 | — | — | US | disclosed |
| WO-1990009798-A1 | IMMOBILIZED CYTOKINES | IMMUNOTHERAPEUTICS, INC. (US) | 1990-09-07 | — | — | WO | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-3965182-A | Preparation of aniline from phenol and ammonia | ETHYL CORPORATION (US) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039279-A1 | Diamide compounds and compositions containing the same | HRH4, HRH2, HRH1 | ALDH1A1 1240/4885MAPT 1936/4885L3MBTL1 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.